A Black female doctor when that was rare, she developed a diagnostic test for the disease that is still a standard tool, as ...

Memantine, a long-approved and cost-effective drug used to treat Alzheimer’s disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...

Memantine, a long-approved and cost-effective drug used to treat Alzheimer’s disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...

Sickle cell anemia is the world's most common genetic disorder. It causes the red blood pigment hemoglobin to crystallize, which results in rigid, malformed red blood cells with a sickle shape. This ...

Memantine, a long-approved and cost-effective drug used to treat Alzheimer's disease, could also benefit patients with sickle cell anemia in the future. Initial clinical data from an international ...

Few companies stand better poised than Beam Therapeutics to reap the first fruits of the FDA’s promised flexibility toward cell and gene therapies. | Riding a regulatory win for its base editing ...

Organ transplants are a "never-ending tragedy," with referrals steadily going up while the number of organs available remains ...

Arguably, the most important thing you can have in this life is your health. No matter how much money you have or resources ...

Most days, our bodies are just there—mundane vessels we inhabit on autopilot. We wake up, get on with our routines, eat, sleep, repeat. But the moment you actually stop and think about what’s ...

Memantine, a cheaply available drug used for decades to treat Alzheimer's, may help prevent sickle cell crises, especially in ...

Researchers received a federal grant to see if diabetes drug empagliflozin is safe and effective for SCD kidney damage.

The Accelerating Pace Of Technological Advancement It feels like every week there’s some new gadget or software ...